Updated: Oct 10, 2026

Analyst Stock Ratings

Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.

Get Alert
Sep 17, 2026
IPHAInnate Pharma
$1.52Get Alert
Aug 12, 2026
IPHAInnate Pharma
$1.52Get Alert
Aug 10, 2026
IPHAInnate Pharma
$1.52Get Alert
Apr 7, 2026
IPHAInnate Pharma
$1.52Get Alert
Mar 12, 2026
IPHAInnate Pharma
$1.52Get Alert
Oct 29, 2025
IPHAInnate Pharma
$1.52Get Alert
Oct 29, 2025
IPHAInnate Pharma
$1.52Get Alert
Sep 18, 2025
IPHAInnate Pharma
$1.52Get Alert
Sep 18, 2025
IPHAInnate Pharma
$1.52—Get Alert
Apr 24, 2025
IPHAInnate Pharma
$1.52Get Alert
Mar 28, 2025
IPHAInnate Pharma
$1.52Get Alert
Feb 6, 2025
IPHAInnate Pharma
$1.52Get Alert
Jan 17, 2025
IPHAInnate Pharma
$1.52Get Alert
Dec 9, 2024
IPHAInnate Pharma
$1.52Get Alert
Nov 15, 2024
IPHAInnate Pharma
$1.52Get Alert
Nov 12, 2024
IPHAInnate Pharma
$1.52Get Alert
Sep 13, 2024
IPHAInnate Pharma
$1.52Get Alert
Jun 12, 2024
IPHAInnate Pharma
$1.52Get Alert
May 15, 2024
IPHAInnate Pharma
$1.52Get Alert
Apr 11, 2024
IPHAInnate Pharma
$1.52Get Alert
Mar 22, 2024
IPHAInnate Pharma
$1.52Get Alert
Nov 15, 2023
IPHAInnate Pharma
$1.52Get Alert
Sep 18, 2023
IPHAInnate Pharma
$1.52Get Alert
Jun 16, 2023
IPHAInnate Pharma
$1.52Get Alert
Mar 24, 2023
IPHAInnate Pharma
$1.52Get Alert
Nov 15, 2022
IPHAInnate Pharma
$1.52Get Alert
Sep 16, 2022
IPHAInnate Pharma
$1.52Get Alert
Aug 2, 2022
IPHAInnate Pharma
$1.52Get Alert
May 11, 2022
IPHAInnate Pharma
$1.52Get Alert
Sep 17, 2021
IPHAInnate Pharma
$1.52Get Alert
Sep 3, 2021
IPHAInnate Pharma
$1.52—Get Alert
Sep 2, 2021
IPHAInnate Pharma
$1.52—Get Alert
Mar 19, 2021
IPHAInnate Pharma
$1.52Get Alert
Dec 15, 2020
IPHAInnate Pharma
$1.52Get Alert
Dec 14, 2020
IPHAInnate Pharma
$1.52—Get Alert
Nov 24, 2020
IPHAInnate Pharma
$1.52Get Alert
Sep 9, 2020
IPHAInnate Pharma
$1.52Get Alert
May 14, 2020
IPHAInnate Pharma
$1.52Get Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free